Sickle cell disease Trials in Houston, United States
Conditions / Sickle cell disease / Houston, United States
Sickle cell disease is a medical condition with active clinical research programs worldwide.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT05031780 | A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) | ACTIVE_NOT_RECRUITING | — |
| NCT00235391 | Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload | COMPLETED | PHASE3 |
| NCT01895361 | Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises | COMPLETED | PHASE2 |
| NCT06612268 | A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease | RECRUITING | — |
| NCT04624659 | A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03815695 | A SAD/MAD to Assess the Safety, PK/PD of FT-4202 in Healthy Volunteers and Sickle Cell Disease Patients | COMPLETED | PHASE1 |
| NCT06609226 | A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia | RECRUITING | PHASE3 |
| NCT05031780 | A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) | ACTIVE_NOT_RECRUITING | — |
| NCT03904134 | Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) | COMPLETED | NA |
| NCT04398628 | ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | RECRUITING | — |